BRCA1 and neoplasm: In the 393 patients in the DPS group with an omental CRS reported, there was no significant difference between the proportion of tumours with CRS3 in the germline BRCA1/2 PV group versus the germline BRCA1/2 wild type group (OR 0.88, 95% CI 0.49–1.63; P = 0.6875) (Table 4).